The central role of antigen presentation in islets of Langerhans in autoimmune diabetes

Current Opinion in Immunology

Volumn 26, Issue 1, 2014, Pages 32-40

  Calderon, Boris ^a   Carrero, Javier A ^a   Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; C PEPTIDE; CD11B ANTIGEN; CHEMOKINE; CYTOKINE; F4/80 ANTIGEN; GLYCOPROTEIN P 15095; HEN EGG WHITE LYSOZYME; INSULIN; LYSOZYME; PEPTIDE; PROTEIN; PROTEIN ZBTB46; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DIABETES; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; DENDRITIC CELL; DIABETES MELLITUS; DIABETOGENIC T CELL; HUMAN; IMMUNOPATHOGENESIS; LYMPH NODE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET CELL FUNCTION; PANCREATIC LYMPH NODE; REVIEW; SECRETORY GRANULE; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; DIABETES MELLITUS, TYPE 1; HOMEOSTASIS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; PEPTIDE FRAGMENTS; SECRETORY VESICLES;

EID: 84887571639     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.10.011     Document Type: Review

References (72)

1. Calderon B., Unanue E.R. Antigen presentation events in autoimmune diabetes. Curr Opin Immunol 2012, 24:119-128.
2. Lacy P.E., Davie J.M., Finke E.H. Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science 1979, 204:312-316.
3. Simeonovic C.J., Bowen K.M., Kotlarski I., Lafferty K.J. Modulation of tissue immunogenicity by organ culture. Comparison of adult islets and fetal pancreas. Transplantation 1980, 30:174-179.
4. Snell G.D. The homograft reaction. Ann Rev Microbiol 1957, 11:439-458.
5. Lafferty K.J., Prowse S.J., Simeonovic C.J. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Ann Rev Immunol 1983, 1:143-173.
6. Calderon B., Suri A., Miller M., Unanue E.R. Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci U S A 2008, 105:6121-6126.
7. Hume D.A., Halpin D., Charlton H., Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of endocrine organs. Proc Natl Acad Sci U S A 1984, 81:4174-4177.
8. Melli K., Friedman R.S., Martin A.E., Finger E.B., Miao G., Szot G.L., Krummel M.F., Tang Q. Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J Immunol 2009, 182:2590-2600.
9. Ginhoux F., Liu K., Heift J., Bogunovic M., Greter M., Hashimoto D., Price J., Yin N., Bromberg J., Lira S.A., Stanley E.R., Nussenzweig M., Merad M. The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med 2009, 206:3115-3130.
10. Satpathy A.T., Albring K.C.W., Edelson J.C., Kretzer B.T., Bhattacharya N.M., Murphy D., Murphy T.L.K.M. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med 2012, 209:1135-1152.
11. Meredith M.M., Liu K., Darrasse-Jeze G., Kamphorst A.O., Schreiber H.A., Guermonprez P., Idoyaga J., Cheong C., Yao K.H., Niec R.E., Nussenzweig M.C. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 2012, 209:1153-1165.
12. Carrero J.A., Calderon B., Towfic F., Artyomov M.N., Unanue E.R. Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS ONE 2013, 8:e59701.
13. Hildner K., Edelson B.T., Purtha W.E., Diamond M., Matsushita H., Kohyama M., Calderon B., Schraml B.U., Unanue E.R., Diamond M.S., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008, 322:1097-1100.
14. Calderon B., Carrero J.A., Miller M.J., Unanue E.R. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci U S A 2011, 108:1561-1566.
15. Cannon W.B. Organization for physiological homeostasis. Physiol Rev 1929, 9:399-431.
16. op macrophage-deficient mice. J Leukocyte Biol 2004, 76:359-367.
17. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
18. Pollard J.W. Trophic macrophages in development and disease. Nature Rev Immunol 2009, 9:259-270.
19. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nature Rev Immunol 2011, 11:723-737.
20. Lammert E., Gu G., McLaughlin M., Brown D., Brekken R., Murtaugh L.C., Gerber H.P., Ferrara N., Melton D.A. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2013, 13:1070-1074.
21. Roberts W.G., Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995, 108:2369-2379.
22. Esser S., Wolburg K., Wolburg H., Breier G., Kurzchalia T., Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998, 140:947-959.
23. Kamba T., Tam B.Y., Hashizume H., Haskell A., Sennino B., Mancuso M.R., Norberg S.M., O'Brien S.M., Davis R.B., Gowen L.C., et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006, 290:H560-H576.
24. Iwashita N., Uchida T., Choi J.B., Azuma K., Ogihara T., Ferrara N., Gerber H., Kaawamori R., Inoue M., Watada H. Impaired insulin secretion in vivo but enhanced insulin secretion from isolated islets in pancreatic beta cell-specific vascular endothelial growth factor-A knock-out mice. Diabetologia 2007, 50:380-389.
25. Haskins K., Portas M., Bradley B., Wegmann D., Lafferty K. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 1988, 37:1444-1448.
26. Shimizu J., Carrasco-Marin E., Kanagawa O., Unanue E.R. Relationship between beta cell injury and antigen presentation in NOD mice. J Immunol 1995, 155:4095-4099.
27. Mohan J.F., Unanue E.R. Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat Rev Immunol 2012, 12:721-728.
28. Mohan J.F., Levisetti M.G., Calderon B., Herzog J.W., Petzold S.J., Unanue E.R. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 2010, 11:350-354.
29. Levisetti M.G., Lewis D.M., Suri A., Unanue E.R. Weak proinsulin peptide-MHC complexes are targeted in autoimmune diabetes in mice. Diabetes 2008, 57:1852-1860.
30. Yin N., Xu J., Ginhoux F., Randolph G.J., Merad M., Ding Y., Bromberg J.S. Functional specialization of islet dendritic cell subsets. J Immunol 2012, 188:4921-4930.
31. DiPaolo R.J., Unanue E.R. The level of peptide-MHC complex determines the susceptibility to autoimmune diabetes: studies in HEL transgenic mice. Eur J Immunol 2001, 31:3453-3459.
32. Byersdorfer C.A., Schweitzer G.G., Unanue E.R. Diabetes is predicted by the beta cell level of autoantigen. J Immunol 2005, 175:4347-4354.
33. Fonseca S.G., Gromada J., Urano F. Endoplasmic reticulum stress and pancreatic β-cell death. Trends Endocrinol Metab 2011, 22:266-274.
34. Mohan J.F., Petzold S.J., Unanue E.R. Register shifting of an autoimmune insulin peptide-MHC II complex allows for the escape of diabetogenic T cells from negative selection. J Exp Med 2011, 208:2375-2383.
35. Mohan J.F., Calderon B., Anderson M.A., Unanue E.R. Pathogenic CD4 T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes. J Exp Med 2013, 210:2403-2414.
36. Wegmann D.R., Eisenbarth G.S. It's insulin. J Autoimmun 2000, 15:286-291.
37. Wegmann D.R., Norbury-Glaser M., Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 1994, 24:1853-1857.
38. Daniel D., Gill R.G., Schloot N., Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995, 25:1056-1062.
39. Halbout P., Briand J.-P., Becourt C., Muller S., Boitard C. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J Immunol 2004, 169:2436-2443.
40. French M.B., Allison J., Cram D.S., Thomas H.E., Dempsey-Collier M., Silva A., Georgiou H.M., Kay T.W., Harrison L.C., Lew A.M. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1997, 46:34-39.
41. Jaeckel E., Lipes M.A., von Boehmer H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol 2004, 5:1028-1035.
42. Lennon G.P., Bettini M., Burton A.R., Vincent E., Arnold P.Y., Santamaria P., Vignai D.A. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 2009, 31:643-653.
43. Calderon B., Carrero J.A., Miller M.J., Unanue E.R. Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response. Proc Natl Acad Sci U S A 2011, 108:567-572.
44. Lieberman S.M., Evans A.M., Han B., Takaki T., Vinnitskaya Y., Caldwell J.A., Serreze D.V., Shabanowitz J., Hunt D.F., Nathenson S.G., et al. Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A 2003, 100:8384-8388.
45. Savinov A.Y., Wong F.S., Stonebraker A.C., Chervonsky A.V. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med 2003, 197:643-656.
46. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., Yu L., Wegmann D.R., Hutton J.C., Elliott J.F., et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005, 435:220-223.
47. Nakayama M., Beilke J.N., Jasinski J.M., Kobayashi M., Miao D., Li M., Coulombe M.G., Liu E., Elliott J.F., Gill R.G., et al. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest 2007, 117:1835-1843.
48. Wayland H. Microcirculation in pancreatic function. Microsc Res Tech 1997, 15:418-433.
49. Liu Y.M., Guth P.H., Kaneko K., Livingston E.H., Brunicardi F.C. Dynamic in vivo observation of rat islet microcirculation. Pancreas 1993, 8:15-21.
50. Nyman L.R., Ford E., Powers A.C., Piston D.W. Glucose-dependent blood flow dynamics in murine pancreatic islets in vivo. Am J Physiol Endocrinol Metab 2010, 298:E807-E814.
51. Wu Q., Salomon B., Chen M., Wang Y., Hoffman L.M., Bluestone J.A., Fu Y.X. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J Exp Med 2001, 193:1327-1332.
52. Ettinger R., Munson S.H., Chao C.C., Vadeboncoeur M., Toma J., McDevitt H.O. A critical role for lymphotoxin-beta receptor in the development of diabetes in nonobese diabetic mice. J Exp Med 2001, 4:1333-1340.
53. Luther S.A., Bidgol A., Hargreaves D.C., Schmidt A., Xi Y., Paniyadi J., Matloubian M., Cyster J.G. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002, 169:424-433.
54. Lee Y., Chin R.K., Christiansen P., Sun Y., Tumanov A.V., Wang J., Chervonsky A.V., Fu Y.X. Recruitment and activation of naïve T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity 2006, 25:499-509.
55. Luther S.A., Lopez T., Bai W., Hanahan D., Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000, 12:471-481.
56. Chen S.C., Vassileva G., Kinsley D., Holzmann S., Manfra D., et al. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol 2002, 168:1001-1008.
57. Rhode A., Pauza M.E., Barral A.M., Rodrigo E., Oldstone M.B., von Herrath M.G., Christen U. Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. J Immunol 2005, 175:3516-3524.
58. Kriegel M.A., Rathinam C., Flavell R.A. Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells. Proc Natl Acad Sci U S A 2012, 109:3457-3462.
59. Picarella D.E., Kratz A., Li C.B., Ruddle N.H., Flavell R.A. Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetic patterns of inflammation in TNF-α and TNF-γ transgenic mice. J Immunol 1993, 150:4136-4150.
60. Faveeuw C., Gagnerault M.C., Kraal G., Lepault F. Homing of lymphocytes into islets of Langerhans in prediabetic non-obese diabetic mice is not restricted to autoreactive T cells. Int Immunol 1995, 7:1905-1913.
61. Qu P., Ji R.C., Kato S. Histochemical analysis of lymphatic endothelial cells in the pancreas of non-obese diabetic mice. J Anat 2003, 203:523-530.
62. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., Santamaria P., Locksley R.M., Krummel M.F., Bluestone J.A. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006, 7:83-92.
63. Gagnerault M.C., Luan J.J., Lotton C., Lepault F. Pancreatic lymph nodes are required for priming of β cell reactive T cells in NOD mice. J Exp Med 2001, 196:369-377.
64. Levisetti M.G., Suri A., Frederick K., Unanue E.R. Absence of lymph nodes in NOD mice treated with lymphotoxin-β receptor immunoglobulin protects from diabetes. Diabetes 2004, 53:3115-3119.
65. Kurts C., Kosaka H., Carbone F.R., Miller J.F., Heath W.R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997, 186:239-245.
66. Kurts C., Miller J.F.A.P., Subramaniam R.M., Carbone F.R., Heath W.R. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998, 188:409-414.
67. Zhang Y., O'Brien B., Trudeau J., Tan R., Santamaria P., Dutz J.P. In situ beta cell death promotes priming of diabetogenc CD8 T lymphocytes. J Immunol 2002, 168:1466-1472.
68. Hoglund P., Mintern J., Waltzinger C., Heath W., Benoist C., Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 1999, 189:331-339.
69. Mintern J.D., Sutherland R.M., Lew A.M., Shortman K., Carbone F.R., Heath W.R. Constitutive, but not inflammatory, cross-presentation is disabled in the pancreas of young mice. Eur J Immunol 2002, 32:1044-1051.
70. Turley S., Poirot L., Hattori M., Benoist C., Mathis D. Physiological β cell death triggers priming of self-reactive T cells by dendritic in a type-1 diabetes model. J Exp Med 2003, 198:1527-1537.
71. Katz J.D., Wang B., Haskins K., Benoist C., Mathis D. Following a diabetogenic T cell receptor from genesis through pathogenesis. Cell 1993, 74:1089-1100.
72. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F., Marrack P., Mahata S.K., Kappler J.W., Haskins K. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.